SG
LABD icon

StoneX Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

StoneX Group’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,128
Closed -$82.7K – 448
2024
Q2 		$82.7K Sell
1,128
-355
-24% -$30K 0.04% 313
2024
Q1 		$108K Buy
+1,483
New +$124K 0.06% 294

Other funds holding LABD

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

StoneX Group's LABD Position: Q3 2024 in Review

StoneX Group sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2024, closing a stake of 1,128 shares — an estimated $82.7K sold.

StoneX Group first reported a position in LABD in Q1 2024 and held it in 2 quarters. The position peaked at $108K in Q1 2024. 15 funds tracked by Wall St. Rank hold LABD as of Q3 2024.

  • StoneX Group reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2024 after selling out during the quarter.
  • StoneX Group sold 1,128 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2024, an estimated $82.7K.
  • StoneX Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2024 and held it in 2 quarters.
  • StoneX Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $108K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2024.

Based on StoneX Group's 13F filing for Q3 2024, filed 12 Nov 2024.